COMMON PHARMACOLOGICAL AND PHYSICOCHEMICAL PROPERTIES OF 5-HT3 BINDING-SITES IN THE RAT CEREBRAL-CORTEX AND NG 108-15 CLONAL CELLS

被引:74
作者
BOLANOS, FJ [1 ]
SCHECHTER, LE [1 ]
MIQUEL, MC [1 ]
EMERIT, MB [1 ]
RUMIGNY, JF [1 ]
HAMON, M [1 ]
GOZLAN, H [1 ]
机构
[1] CTR RECH DELALANDE,F-92500 RUEIL MALMAISON,FRANCE
关键词
D O I
10.1016/0006-2952(90)90452-Q
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
On account of the postulated existence of 5-HT3 receptor subtypes, the respective physicochemical and pharmacological properties of specific binding sites for the potent 5-HT3 antagonist [3H]zacopride were compared using membranes from the rat posterior cortex or neuroblastoma-glioma NG 108-15 clonal cells. In both membrane preparations, [3H]zacopride bound to a single class of specific sites with a Kd close to 0.5 nM. However, the Bmax value in NG 108-15 cell membranes (970 ± 194 mol/ mg protein) was approximately 50 times larger than that in cortical membranes (19 ± 2 mol/mg protein). The specific binding of [3H]zacopride was equally affected by temperature, pH and molarity of the assay medium, and equally insensitive to thiol- and disulfide-reagents (N-ethylmaleimide, p-chloro-mercuribenzene sulfonic acid, dithiothreitol) and GTP in cortical as well as NG 108-15 cell membranes. Determination of the molecular size of [3H]zacopride specific binding sites by radiation inactivation yielded values close to 35 kDa for both membrane preparations. Finally, a highly significant positive correlation (r = 0.979) was found between the respective pKi values of 34 different drugs for their inhibition of [3H]zacopride specific binding to cortical or NG 108-15 cell membranes. Among them, the most potent was S(-)zacopride (pKi = 9.55), followed by BRL 43964, ICS 205-930, quipazine, R(+)zacopride, GR 38032F and MDL 72222. Atyplcal antidepressants (mianserin, amoxapine) and neuroleptics (clotiapine, loxapine and clozapine) were active in rather low concentrations (pKi < 6.5), suggesting that recognition of 5-HT3 sites might be relevant to part of the in vivo effects of these drugs. Such identical physico-chemical and pharmacological properties of [3H]zacopride specific binding in cortical and NG 108-15 cell membranes strongly suggest that the same 5-HT3 receptor (subtype ?) exists in these two preparations. © 1990.
引用
收藏
页码:1541 / 1550
页数:10
相关论文
共 42 条
[1]   DIFFERENTIAL EFFECT OF TYPICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS ON THE SUPPRESSANT ACTION OF 2-METHYLSEROTONIN ON MEDIAL PREFRONTAL CORTICAL-CELLS - A MICROIONTOPHORETIC STUDY [J].
ASHBY, CR ;
EDWARDS, E ;
HARKINS, KL ;
WANG, RY .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (03) :583-584
[2]   5-HT3 RECEPTORS MEDIATE INHIBITION OF ACETYLCHOLINE-RELEASE IN CORTICAL TISSUE [J].
BARNES, JM ;
BARNES, NM ;
COSTALL, B ;
NAYLOR, RJ ;
TYERS, MB .
NATURE, 1989, 338 (6218) :762-763
[3]   IDENTIFICATION OF 5-HT3 RECOGNITION SITES IN HUMAN-BRAIN TISSUE USING (H-3) ZACOPRIDE [J].
BARNES, NM ;
COSTALL, B ;
IRONSIDE, JW ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (09) :668-668
[4]   [H-3] ZACOPRIDE - LIGAND FOR THE IDENTIFICATION OF 5-HT3 RECOGNITION SITES [J].
BARNES, NM ;
COSTALL, B ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (08) :548-551
[5]   ACTIVATION OF A 5-HT3 RECEPTOR RELEASES DOPAMINE FROM RAT STRIATAL SLICE [J].
BLANDINA, P ;
GOLDFARB, J ;
GREEN, JP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (03) :349-350
[6]   EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, GR38032F, ON RAISED DOPAMINERGIC ACTIVITY IN THE MESOLIMBIC SYSTEM OF THE RAT AND MARMOSET BRAIN [J].
COSTALL, B ;
DOMENEY, AM ;
NAYLOR, RJ ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) :881-894
[7]   5-HT3 RECEPTORS ARE MEMBRANE ION CHANNELS [J].
DERKACH, V ;
SURPRENANT, A ;
NORTH, RA .
NATURE, 1989, 339 (6227) :706-709
[8]   SEROTONIN (5-HT) ENHANCES HIPPOCAMPAL NORADRENALINE (NA) RELEASE - EVIDENCE FOR FACILITATORY 5-HT RECEPTORS WITHIN THE CNS [J].
FEUERSTEIN, TJ ;
HERTTING, G .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 333 (03) :191-197
[9]   DETERMINATION OF THE MOLECULAR-SIZE OF THE 5-HT3 RECEPTOR-BINDING SITE BY RADIATION INACTIVATION [J].
GOZLAN, H ;
SCHECHTER, LE ;
BOLANOS, F ;
EMERIT, MB ;
MIQUEL, MC ;
NIELSEN, M ;
HAMON, M .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1989, 172 (06) :497-500
[10]   INSITU MOLECULAR SIZES OF THE VARIOUS TYPES OF 5-HT BINDING-SITES IN THE RAT-BRAIN [J].
GOZLAN, H ;
EMERIT, MB ;
HALL, MD ;
NIELSEN, M ;
HAMON, M .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (11) :1891-1897